Structural and functional properties of staphylococcal superantigen-like protein 4

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 4004-4013

  Hermans, Stefan J ^a   Baker, Heather M ^a   Sequeira, Richard P ^a   Langley, Ries J ^a   Baker, Edward N ^a   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBOHYDRATE; GLYCAN; GLYCOPROTEIN; SIALIC ACID; SIALYL LEWIS X ANTIGEN; SIALYLLACTOSAMINE; STAPHYLOCOCCAL SUPERANTIGEN LIKE PROTEIN; STAPHYLOCOCCAL SUPERANTIGEN LIKE PROTEIN 11; STAPHYLOCOCCAL SUPERANTIGEN LIKE PROTEIN 4; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; BINDING SITE; BIOSENSOR; BONE MARROW CELL; CRYSTAL STRUCTURE; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; EXOTOXINS; HUMANS; N-ACETYLNEURAMINIC ACID; PROTEIN BINDING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 84867594362     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00764-12     Document Type: Article

References (42)

1. Adams PD, et al. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58:1948-1954.
2. Arcus VL, Langley R, Proft T, Fraser JD, Baker EN. 2002. The threedimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J. Biol. Chem. 277: 32274-32281.
3. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. 2008. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J. Bacteriol. 190:300 -310.
4. Baker HM, et al. 2007. Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J. Mol. Biol. 374:1298 -1308.
5. Bardoel BW, et al. 20 June 2012. Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J. Mol. Med. [Epub ahead of print.] doi:10.1007/s00109-012-0926-8.
6. Benson MA, et al. 2011. Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol. Microbiol. 81:659-675.
7. Bestebroer J, et al. 2007. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109: 2936-2943.
8. Bishop JR, Gagneux P. 2007. Evolution of carbohydrate antigensmicrobial forces shaping host glycomes? Glycobiology 17:23R-34R.
9. Bronner S, Monteil H, Prevost G. 2004. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol. Rev. 28:183-200.
10. Chenna R, et al. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-3500.
11. Chung MC, et al. 2007. The crystal structure of staphylococcal superantigenlike protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol. Microbiol. 66:1342-1355.
12. Collaborative Computational Project No. 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760 -763.
13. Daigneault M, Preston JA, Marriott HM, Whyte MKB, Dockrell DH. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5:e8668. doi:10.1371/journal.pone.0008668.
14. Davis IW, Murray LW, Richardson JS, Richardson DC. 2004. Mol-Probity: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32:W615-W619.
15. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126 -2132.
16. Feizi T. 2000. Carbohydrate-mediated recognition systems in innate immunity. Immunol. Rev. 173:79-88.
17. Foster TJ. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3:948 -958.
18. Foster TJ. 2004. The Staphylococcus aureus "superbug." J. Clin. Invest. 114:1693-1696.
19. Fridkin SK, et al. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436 -1444.
20. Herbert S, et al. 2007. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3:e102. doi:10.1371/journal.ppat.0030102.
21. Holden MTG, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101:9786 -9791.
22. Jongerius I, et al. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204:2461-2471.
23. Kabsch W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry land cell constants. J. Appl. Crystallogr. 26:795-800.
24. Kuroda M, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
25. Langley R, Patel D, Jackson N, Clow F, Fraser JD. 2010. Staphylococcal superantigen super-domains in immune evasion. Crit. Rev. Immunol. 30:149 -165.
26. Langley R, et al. 2005. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcαRI binding and serum killing of bacteria. J. Immunol. 174:2926 -2933.
27. Laursen NS, et al. 2010. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 107:3681-3686.
28. Lindsay JA, Holden MTG. 2006. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct. Integr. Genomics 6:186 -201.
29. Lowy FD. 1998. Medical progress: Staphylococcus aureus infections. N. Engl. J. Med. 339:520 -532.
30. Luong TT, Lee CY. 2002. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infect. Immun. 70:3389-3395.
31. Moreland N, et al. 2005. A flexible and economical medium-throughput strategy for protein production and crystallization. Acta Crystallogr. D Biol. Crystallogr. 61:1378 -1385.
32. Munro JM, et al. 1992. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am. J. Pathol. 141:1397-1408.
33. Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240 -255.
34. Papageorgiou AC, Acharya KR. 2000. Microbial superantigens: from structure to function. Trends Microbiol. 8:369 -375.
35. Patel D, Wines BD, Langley RJ, Fraser JD. 2010. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J. Immunol. 184:6283-6292.
36. Ramsland PA, et al. 2007. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc. Natl. Acad. Sci. U. S. A. 104:15051-15056.
37. Rooijakkers SHM, Van Kessel KPM, Van Strijp JAG. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13:596-601.
38. Shopsin B, et al. 2008. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J. Infect. Dis. 198:1171-1174.
39. Storoni LC, McCoy AJ, Read RJ. 2004. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D Biol. Crystallogr. 60:432-438.
40. Varki A. 2007. Glycan-based interactions involving vertebrate sialic-acidrecognizing proteins. Nature 446:1023-1029.
41. Voyich JM, et al. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175: 3907-3919.
42. Wilson GJ, et al. 2011. A novel core genome-encoded superantigen contributes to lethality of community-associatedMRSAnecrotizing pneumonia. PLoS Pathog. 7:e1002271. doi:10.1371/journal.ppat.1002271.